000 01434 a2200409 4500
005 20250517050833.0
264 0 _c20170113
008 201701s 0 0 eng d
022 _a1743-1328
024 7 _a10.1179/1743132815Y.0000000089
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSubirós, Nelvys
245 0 0 _aAssessment of dose-effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy.
_h[electronic resource]
260 _bNeurological research
_cMar 2016
300 _a187-95 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aEpidermal Growth Factor
_xtherapeutic use
650 0 4 _aGerbillinae
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeurologic Examination
650 0 4 _aOligopeptides
_xtherapeutic use
650 0 4 _aStroke
_xdrug therapy
650 0 4 _aTime Factors
700 1 _aPérez-Saad, Héctor M
700 1 _aBerlanga, Jorge A
700 1 _aAldana, Lizet
700 1 _aGarcía-Illera, Gerardo
700 1 _aGibson, Claire L
700 1 _aGarcía-Del-Barco, Diana
773 0 _tNeurological research
_gvol. 38
_gno. 3
_gp. 187-95
856 4 0 _uhttps://doi.org/10.1179/1743132815Y.0000000089
_zAvailable from publisher's website
999 _c25206050
_d25206050